KaloCyte

Kalo Cyte

Biotechnology, 670 W Baltimore St. HSRF III Fl 8, Baltimore, Maryland, 21201, United States, 1-10 Employees

kalocyte.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 31********

Who is KALOCYTE

KaloCyte, Inc., a preclinical biotech that has developed an artificial RBC substitute for use as a lifeline when blood is not available. We are located at the University of Maryland, Balt...

Read More

map
  • 670 W Baltimore St. HSRF III Fl 8, Baltimore, Maryland, 21201, United States Headquarters: 670 W Baltimore St. HSRF III Fl 8, Baltimore, Maryland, 21201, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from KALOCYTE

KaloCyte Org Chart and Mapping

Employees

Shelby McCauley

Associate Scientist- Laboratory Operations Manager

Esma Demir

Formulation Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding KaloCyte

Answer: KaloCyte's headquarters are located at 670 W Baltimore St. HSRF III Fl 8, Baltimore, Maryland, 21201, United States

Answer: KaloCyte's phone number is 31********

Answer: KaloCyte's official website is https://kalocyte.com

Answer: KaloCyte's revenue is $1 Million to $5 Million

Answer: KaloCyte's SIC: 8731

Answer: KaloCyte has 1-10 employees

Answer: KaloCyte is in Biotechnology

Answer: KaloCyte contact info: Phone number: 31******** Website: https://kalocyte.com

Answer: KaloCyte, Inc., a preclinical biotech that has developed an artificial RBC substitute for use as a lifeline when blood is not available. We are located at the University of Maryland, Baltimore (UMB) as an Affiliate of the UM BioPark. KaloCytes offices and labs are sited within the UM School of Medicines Center for Blood Oxygen Transport and Hemostasis (CBOTH) directed by Allan Doctor, MD (KaloCyte Co-Founder and CSO). KaloCyte was founded in 2016 by a distinguished team of Washington University in St. Louis researchers in physiology, bioengineering, and trauma care, with support from the BioGenerator Fundamentals program. KaloCyte has demonstrated preclinical safety and efficacy for ErythroMer, a shelf-stable, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. KaloCyte is supported by $14M in federal awards and $5M investor funding. ErythroMer is a first-in-class, bio-inspired nanoparticle-encapsulated human hemoglobin, which mimics the vital oxygen-carrying functionality of RBCs and can be freeze-dried for long-term storage. Erythromers synthetic outer membrane, small size and surface area allow for physiologically realistic gas exchange. The synthetic polymer shell is immune-silent, inert and carries no blood antigens, eliminating the need to type and cross-match as with stored blood. ErythroMer can be freeze-dried or lyophilized, for a much longer shelf life than stored blood. It is covered by issued U.S. patents that specify composition of matter, method of preparation, and use as an oxygen carrier.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access